CELH
Celsius Holdings, Inc.
CELH has the edge over HLF overall, supported by stronger fundamentals and stronger valuation.
HLF
Herbalife Nutrition Ltd.
HLF's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HLF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Stable |
HLF's cash flow is currently healthy, and its revenue, profitability and balance sheet are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over HLF in the historical PE scenario, which offers more potential upside but is not a forecast.
HLF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.9x | $8.29 | -46% |
| Forward | 5.4x | $15.21 | — |
| Fair | 7.6x | $12.78 | -16% |
| Current | 9.1x | $15.21 | — |
| Expensive | 16x | $27.34 | +80% |
Historical ranges are pointers, not guarantees.
HLF's PE is in its fair range at 9.1x. If earnings grow as analysts expect, today's price would be 5.4x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over HLF on the outlook, with more favorable revenue expectations.
HLF Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect HLF's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
HLF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.82 | +68% |
| Q3 2026 | $1.68 | -46% |
| Q2 2026 | $1.55 | -51% |
| Q1 2026 | $2.28 | -17% |
| Q4 2025 | $2.20 | -12% |
| Q3 2025 | $3.14 | +269% |
| Q2 2025 | $3.18 | +288% |
| Q1 2025 | $2.75 | +101% |
| Q4 2024 | $2.50 | +76% |
HLF has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over HLF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over HLF on profitability, with a higher operating margin.
HLF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +6% |
| Q2 2026 | $1.3B | +5.4% |
| Q1 2026 | $1.3B | +7.8% |
| Q4 2025 | $1.3B | +6.3% |
| Q3 2025 | $1.3B | +2.7% |
| Q2 2025 | $1.3B | -1.7% |
| Q1 2025 | $1.2B | -3.4% |
| Q4 2024 | $1.2B | -0.6% |
HLF's revenue has grown year over year for five quarters in a row: $1.4B last quarter, up 6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | +0.4 points |
| Q2 2026 | 9.7% | -0.9 points |
| Q1 2026 | 11% | +0.5 points |
| Q4 2025 | 7.8% | -1 points |
| Q3 2025 | 9.9% | -0.4 points |
| Q2 2025 | 11% | +4.2 points |
| Q1 2025 | 10% | +4.4 points |
| Q4 2024 | 8.8% | +4.2 points |
HLF's operating margin was 10% last quarter, about level with the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
HLF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $132.8M | +13% |
| Q2 2026 | $21.6M | -70% |
| Q1 2026 | $102.9M | +$121M |
| Q4 2025 | $79.8M | +82% |
| Q3 2025 | $118M | +63% |
| Q2 2025 | $73.2M | +11% |
| Q1 2025 | -$18.1M | +$1M |
| Q4 2024 | $43.9M | -28% |
HLF has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over HLF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
HLF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.7% | +2.8M shares |
| 1 year | +3.2% | +3.3M shares |
| 3 years | +6.9% | +6.9M shares |
| 5 years | -0.5% | -500K shares |
| Available history | -24% | -34.3M shares |
HLF has 107M diluted shares, up 3.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200,000 |
| Q2 2026 | $9.3M |
| Q1 2026 | $700,000 |
| Q4 2025 | $100,000 |
| Q3 2025 | $1.3M |
| Q2 2025 | $4.6M |
| Q1 2025 | $2.2M |
| Q4 2024 | $2.6M |
HLF spent $10M buying back its own shares over the past year, down 3.7% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over HLF on leverage, with a lower net debt burden relative to earnings.
HLF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 3.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | 3.6x | Elevated |
HLF's net debt is about 2.4 years of its operating earnings (EBITDA), down from 2.8 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
HLF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.1 | Neutral |
| Stochastic | 79.3 | Neutral |
HLF's weekly RSI is 61 (neutral) and its Stochastic is 79 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
HLF PE vs Consumer Defensive Sector
| Metric | HLF | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 19x | 54% below |
| PE % | 64 | 18 | 46 pts above |
HLF has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
HLF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.7 | 11% above |
| 20 week MA | $12.9 | 18% above |
| 50 week MA | $14.0 | 8.3% above |
| 100 week MA | $11.1 | 37% above |
| 200 week MA | $11.7 | 30% above |
HLF has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
HLF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.8 | $48.4 | +1.3% |
| 2021 | $48.4 | $40.2 | -17% |
| 2022 | $40.2 | $14.5 | -64% |
| 2023 | $14.5 | $15.3 | +5.6% |
| 2024 | $15.3 | $6.70 | -56% |
| 2025 | $6.70 | $13.3 | +99% |
| 2026 YTD | $13.3 | $15.2 | +14% |
HLF has the edge over CELH on returns for 2026, with the stronger performance.